Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Mangoceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Mangoceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Cohen Jacob D. | Chief Executive Officer | 500,000 | Mar 20, 2026 | 3 |
| Tiger Cub Trust | 10% Owner | 500,000 | Mar 20, 2026 | 3 |
| Johnston Eugene M | CFO | 120,000 | Dec 17, 2025 | 3 |
| Hamilton Alex P. | Director | 3,334 | Nov 26, 2025 | 1 |
| Myers Kenny | Director | 136,667 | Sep 12, 2025 | 0 |
| D'Alessio Lorraine Pamela | Director | 136,667 | Sep 12, 2025 | 0 |
| Isaac Antonios | President | 60,000 | Apr 11, 2025 | 0 |
| Hammer Amanda Elizabeth | Chief Operating Officer | 175,000 | Jun 5, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Johnston Eugene MCFO | SSale | −3.33K | $1.17 | −$3.90K | −2.7%120.0K after | |
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Johnston Eugene MCFO | SSale | −5.00K | $1.20 | −$6.00K | −3.9%123.3K after | |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Johnston Eugene MCFO | SSale | −10.0K | $1.13 | −$11.3K | −7.2%128.3K after | |
| Nov 26, 2025 (view filing) | Nov 19 | 7 daysLate | Hamilton Alex P.Director | SSale | −125.0K | $1.22 | −$152.5K | −97.4%3.33K after | |
| Jun 27, 2024 (view filing)6:25 PM ET | Jun 25-26 | 2 days | Hamilton Alex P.Director | SSale | −125.0K | $0.3187 | −$39.8K | −71.4%50.0K after | 2 lots |
| May 2, 2023 (view filing)8:50 PM ET | Apr 10 | 22 daysLate | Cohen Jacob D. and 1 otherChief Executive Officer | PPurchase | +275.0K | $1.00 | +$275.0K | +3.4%8.28M after |